These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37104698)

  • 1. A Carrier-Free Nanomedicine Enables Apoptosis-Ferroptosis Synergistic Breast Cancer Therapy by Targeting Subcellular Organelles.
    Zhu J; Zhang K; Zhou Y; Wang R; Gong L; Wang C; Zhong K; Liu W; Feng F; Qu W
    ACS Appl Mater Interfaces; 2023 May; 15(18):22403-22414. PubMed ID: 37104698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
    Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
    Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Au-Fe
    Wei R; Fu G; Li Z; Liu Y; Qi L; Liu K; Zhao Z; Xue M
    J Colloid Interface Sci; 2024 Jun; 663():644-655. PubMed ID: 38430834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
    Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
    J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
    Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
    Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chemo/chemodynamic nanoparticle based on hyaluronic acid induces ferroptosis and apoptosis for triple-negative breast cancer therapy.
    Wang N; Zhang Q; Wang Z; Liu Y; Yang S; Zhao X; Peng J
    Carbohydr Polym; 2024 Apr; 329():121795. PubMed ID: 38286559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eupaformosanin induces apoptosis and ferroptosis through ubiquitination of mutant p53 in triple-negative breast cancer.
    Wei Y; Zhu Z; Hu H; Guan J; Yang B; Zhao H
    Eur J Pharmacol; 2022 Jun; 924():174970. PubMed ID: 35469839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Intervention Nanoparticles for Triple-Negative Breast Cancer Therapy via Overcoming FSP1-Mediated Ferroptosis Resistance.
    Yang J; Jia Z; Zhang J; Pan X; Wei Y; Ma S; Yang N; Liu Z; Shen Q
    Adv Healthc Mater; 2022 Jul; 11(13):e2102799. PubMed ID: 35395704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.
    Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: A dual-death therapy for triple negative breast cancer.
    Ghadi R; Pandey PK; Gabhale A; Wadikar A; Dharshini M; Kuche K; Date T; Jain S
    Int J Pharm; 2023 Dec; 648():123570. PubMed ID: 37918494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-Polyphenol-Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin Toxification.
    Zhou L; Chen J; Li R; Wei L; Xiong H; Wang C; Chai K; Chen M; Zhu Z; Yao T; Lin Y; Dong C; Shi S
    Small; 2021 Nov; 17(47):e2103919. PubMed ID: 34623753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin induced ferroptosis for triple-negative breast cancer therapy.
    Yao X; Xie R; Cao Y; Tang J; Men Y; Peng H; Yang W
    J Nanobiotechnology; 2021 Oct; 19(1):311. PubMed ID: 34627266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diselenium-linked dimeric prodrug nanomedicine breaking the intracellular redox balance for triple-negative breast cancer targeted therapy.
    Chen M; Zhang M; Lu X; Li Y; Lu C
    Eur J Pharm Biopharm; 2023 Dec; 193():16-27. PubMed ID: 37865134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
    Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
    J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiliroside induces ferroptosis to repress the development of triple-negative breast cancer cells.
    Hu C; Zhao JF; Wang YM; Wu XL; Ye L
    Tissue Cell; 2023 Aug; 83():102116. PubMed ID: 37301139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis.
    Zhao Y; Ruan X; Cheng J; Xu X; Gu M; Mueck AO
    Climacteric; 2023 Apr; 26(2):135-142. PubMed ID: 36724820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-Infrared Phototheranostic Iron Pyrite Nanocrystals Simultaneously Induce Dual Cell Death Pathways via Enhanced Fenton Reactions in Triple-Negative Breast Cancer.
    Zhao C; Liu Z; Chang CC; Chen YC; Zhang Q; Zhang XD; Andreou C; Pang J; Liu ZX; Wang DY; Kircher MF; Yang J
    ACS Nano; 2023 Mar; 17(5):4261-4278. PubMed ID: 36706095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis: the emerging player in remodeling triple-negative breast cancer.
    Li J; He D; Li S; Xiao J; Zhu Z
    Front Immunol; 2023; 14():1284057. PubMed ID: 37928550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy.
    Yang F; Xiao Y; Ding JH; Jin X; Ma D; Li DQ; Shi JX; Huang W; Wang YP; Jiang YZ; Shao ZM
    Cell Metab; 2023 Jan; 35(1):84-100.e8. PubMed ID: 36257316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.